Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

Market Closed
23 Feb, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
14. 83
+0.43
+2.99%
$
1.9B Market Cap
- P/E Ratio
- Div Yield
1,017,424 Volume
-0.52 Eps
$ 14.4
Previous Close
Day Range
14.32 14.98
Year Range
6.55 16.54
Want to track AUPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AUPH earnings report is expected in 2 days (26 Feb 2026)
Name Time Cons. EPS Eps
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
11 May 2026 (In 2 months)
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
30 Apr 2026 (In 2 months)
0.16
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
4 Mar 2026 (In 1 week)
0.15
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
26 Feb 2026 (In 2 days)
0.21
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
6 Nov 2025
0.16
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
30 Oct 2025
0.15
0.23
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
31 Jul 2025
0.14
0.16
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
30 Apr 2025
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
13 Feb 2025
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
31 Oct 2024
0.01
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
1 Aug 2024
0.01
0.01
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
14 Jun 2024
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
2 May 2024
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
15 Feb 2024
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
2 Nov 2023
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
4 Nov 2016
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
5 Aug 2016
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
11 May 2016
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
18 Mar 2016
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
13 Nov 2015
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
4 Aug 2015
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
15 May 2015
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
30 Mar 2015
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
12 Nov 2014
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
15 Aug 2014
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
16 May 2014
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
28 Mar 2014
-
0.11
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
22 Nov 2013
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
14 Aug 2013
-
-
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
16 May 2013
-
-

AUPH Earnings Reports FAQ

What is the earnings per share (EPS) for AUPH?

The current EPS is -0.52.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 6.66%, reflecting the AUPH's performance and NASDAQ (NMS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-26, based on the AUPH's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Aurinia Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for AUPH at this time, as Aurinia Pharmaceuticals Inc has no recent EPS data to calculate it.